BACKGROUND: Breast cancer and its treatment introduce numerous physiologic, psychological, social, and economic stressors to a woman with the diagnosis. Allostatic load, a composite score of biomarkers representing physiologic dysregulation, may serve as a measure of the biological burden of breast cancer. This study investigates the association between breast cancer and allostatic load scores by comparing allostatic load scores in those with a history of breast cancer to those without, stratified by race. METHODS: Black and white women aged 35 to 85 were analyzed using the data from NHANES 1999-2008 (n = 4875 women, of which 188 women had a history of breast cancer). Stratified by race, we ran multivariate analyses with history of breast cancer as a predictor for elevated allostatic load while adjusting for other potentially confounding variables. RESULTS: Although a history of breast cancer was not associated with elevated allostatic load in white women, it was significantly associated with elevated allostatic load in black women after adjusting for age, income, education, insurance type, smoking status, alcohol intake, and physical activity [Odds Ratio (OR) 2.08 (95%CI 1.02, 4.22)]. Furthermore, an interaction between black and having a history of breast cancer was found to be significant in predicting elevated allostatic load scores after adjusting for demographic, behavioral, and comorbidity characteristics. CONCLUSIONS: These results suggest that the biological toll of breast cancer may be greater in black women than white women.
BACKGROUND:Breast cancer and its treatment introduce numerous physiologic, psychological, social, and economic stressors to a woman with the diagnosis. Allostatic load, a composite score of biomarkers representing physiologic dysregulation, may serve as a measure of the biological burden of breast cancer. This study investigates the association between breast cancer and allostatic load scores by comparing allostatic load scores in those with a history of breast cancer to those without, stratified by race. METHODS: Black and white women aged 35 to 85 were analyzed using the data from NHANES 1999-2008 (n = 4875 women, of which 188 women had a history of breast cancer). Stratified by race, we ran multivariate analyses with history of breast cancer as a predictor for elevated allostatic load while adjusting for other potentially confounding variables. RESULTS: Although a history of breast cancer was not associated with elevated allostatic load in white women, it was significantly associated with elevated allostatic load in black women after adjusting for age, income, education, insurance type, smoking status, alcohol intake, and physical activity [Odds Ratio (OR) 2.08 (95%CI 1.02, 4.22)]. Furthermore, an interaction between black and having a history of breast cancer was found to be significant in predicting elevated allostatic load scores after adjusting for demographic, behavioral, and comorbidity characteristics. CONCLUSIONS: These results suggest that the biological toll of breast cancer may be greater in black women than white women.
Authors: Vickie M Mays; Robert-Paul Juster; Timothy J Williamson; Teresa E Seeman; Susan D Cochran Journal: Psychosom Med Date: 2018 Jul/Aug Impact factor: 4.312
Authors: Michelle T Duong; Brianna A Bingham; Paola C Aldana; Stephanie T Chung; Anne E Sumner Journal: J Racial Ethn Health Disparities Date: 2016-06-28
Authors: Xiaoli Chen; Susan Redline; Alexandra E Shields; David R Williams; Michelle A Williams Journal: Ann Epidemiol Date: 2014-06-06 Impact factor: 3.797
Authors: Erik J Rodriquez; Edward N Kim; Anne E Sumner; Anna M Nápoles; Eliseo J Pérez-Stable Journal: J Urban Health Date: 2019-03 Impact factor: 3.671
Authors: Danielle Gianferante; Myriam V Thoma; Luke Hanlin; Xuejie Chen; Juliana G Breines; Peggy M Zoccola; Nicolas Rohleder Journal: Psychoneuroendocrinology Date: 2014-08-01 Impact factor: 4.905
Authors: Cathleen Y Xing; Michelle Doose; Bo Qin; Yong Lin; Tiffany L Carson; Jesse J Plascak; Kitaw Demissie; Chi-Chen Hong; Elisa V Bandera; Adana A M Llanos Journal: Breast Cancer Res Treat Date: 2020-09-10 Impact factor: 4.872